Recurrence-free survival rates were similar, even when patients quit adjuvant immunotherapy early, according to a new report.

Immune checkpoint (IC) inhibitor drug holidays are safe in patients with metastatic melanoma who achieve an objective response (OR) during therapy, according to a study of more than 200 patients in ...

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

Advanced melanoma patients in England are set to be fast-tracked into a clinical trial of a new skin cancer vaccine after the NHS partnered with Oxford-based Scancell to widen access across the ...

The clinical trial (NCT04079166) is part of the NHS Cancer Vaccine Launch Pad (CVLP), a framework launched in May 2024 to ...

In the trial, researchers are evaluating Scancell's DNA cancer vaccines SCIB1 and iSCIB1+ alongside immunotherapy.

Several patient-specific factors are associated with an increased rate of advanced melanoma at presentation, including age, gender, and race.

Malignant melanoma (MM) is among the most lethal cutaneous neoplasms, frequently tied to metastasis and poor outcomes. Neural cell adhesion molecule L1 (L1CAM) is a protein that has been associated ...